Table 2.
Results of a Correlation Analysis of Leg Muscle Strength and Clinical Characteristics.
| All patients (n=132) | r | p value | ||
|---|---|---|---|---|
| Sex (male: 0, female: 1) | -0.369 | <0.001 | ||
| Age | -0.290 | 0.001 | ||
| Age of disease onset | -0.258 | 0.003 | ||
| Disease duration | 0.149 | 0.087 | ||
| H&Y stage | -0.447 | <0.001 | ||
| BMI | 0.033 | 0.704 | ||
| Barthel index | 0.451 | <0.001 | ||
| Levodopa equivalent dose | 0.076 | 0.384 | ||
| MMSE score | 0.304 | <0.001 | ||
| Stride length | 0.562 | <0.001 | ||
| Stride time | -0.387 | <0.001 | ||
| Gait velocity | 0.611 | <0.001 | ||
| Cadence | 0.388 | <0.001 | ||
| Timed up and go test | -0.652 | <0.001 |
Spearman’s rank correlation analysis was performed.